Home > Boards > US OTC > Biotechs > Sangamo Biosciences Inc. (SGMO)

Bought some on the dip today hoping to

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
FXR Guy Member Profile
 
Followed By 1
Posts 22
Boards Moderated 0
Alias Born 08/02/18
160x600 placeholder
Sangamo Therapeutics Appoints Bettina M. Cockroft, MD, MBA, as Senior Vice President and Chief Medical Officer Business Wire - 9/30/2019 4:15:00 PM
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences Business Wire - 9/30/2019 8:30:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/26/2019 6:16:05 PM
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences Business Wire - 8/30/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2019 5:11:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2019 5:05:41 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2019 4:45:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2019 4:38:07 PM
Sangamo Therapeutics Reports Second Quarter 2019 Financial Results Business Wire - 8/7/2019 4:01:00 PM
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences Business Wire - 8/6/2019 4:05:00 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/6/2019 4:03:48 PM
Sangamo Therapeutics Appoints Gary H. Loeb as Executive Vice President and General Counsel Business Wire - 7/31/2019 4:15:00 PM
Sangamo Therapeutics Announces Second Quarter 2019 Conference Call and Webcast Business Wire - 7/31/2019 4:05:00 PM
Sangamo Announces Nature Biotechnology Publication of New Strategies for Optimizing the Specificity of Gene Editing Nucleases Business Wire - 7/29/2019 11:00:00 AM
Sangamo et Pfizer annoncent des résultats de phase 1/2 mis à jour pour la thérapie génique expérimentale de l’hémoph... Business Wire - 7/8/2019 10:05:00 AM
Sangamo Therapeutics Up 17%; Unveiled Updated Study Data Dow Jones News - 7/8/2019 8:43:00 AM
Sangamo & Pfizer Announce Updated Phase 1/2 Results for SB-525 Investigational Hemophilia A Gene Therapy Showing Sustained In... Business Wire - 7/5/2019 11:15:00 PM
 Sangamo Therapeutics Announces Nature Medicine Publication Detailing the Activity of Disease Allele-Selective Zinc Finger P... Business Wire - 7/1/2019 11:00:00 AM
Sangamo Announces Upcoming Presentation Of Investigational SB-525 Hemophilia A Gene Therapy Data At ISTH 2019 PR Newswire (US) - 6/21/2019 9:16:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/18/2019 5:03:05 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2019 4:03:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2019 5:14:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2019 5:10:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2019 5:09:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2019 5:08:23 PM
FXR Guy   Thursday, 02/07/19 02:43:16 PM
Re: None
Post # of 340 
Bought some on the dip today hoping to average down. Looking good so far

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist